| Literature DB >> 34085043 |
Tatyana V Popova1,2, Olesya A Krumkacheva2,3, Anna S Burmakova1,2, Anna S Spitsyna2,4, Olga D Zakharova1, Vladimir A Lisitskiy1, Igor A Kirilyuk4, Vladimir N Silnikov1, Michael K Bowman4,5, Elena G Bagryanskaya2,4, Tatyana S Godovikova1.
Abstract
As the most abundant protein with a variety of physiological functions, albumin has been used extensively for the delivery of therapeutic molecules. Thiolactone chemistry provides a powerful tool to prepare spin-labeled albumin-based multimodal imaging probes and therapeutic agents. We report the synthesis of a tamoxifen homocysteine thiolactone derivative and its use in thiol-'click' chemistry to prepare multi-functionalized serum albumin. The released sulfhydryl group of the homocysteine functional handle was labeled with a nitroxide reagent to prepare a spin-labeled albumin-tamoxifen conjugate confirmed by MALDI-TOF-MS, EPR spectroscopy, UV-vis and fluorescent emission spectra. This is the basis for a novel multimodal tamoxifen-albumin theranostic with a significant (dose-dependent) inhibitory effect on the proliferation of malignant cells. The response of human glioblastoma multiforme T98G cells and breast cancer MCF-7 cells to tamoxifen and its albumin conjugates was different in tumor cells with different expression level of ERα in our experiments. These results provide further impetus to develop a serum protein for delivery of tamoxifen to cancer cells. This journal is © The Royal Society of Chemistry.Entities:
Year: 2020 PMID: 34085043 PMCID: PMC8126878 DOI: 10.1039/c9md00516a
Source DB: PubMed Journal: RSC Med Chem ISSN: 2632-8682